• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Forbion Capital Partners

edit

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion’s investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.

Recent Milestones

edit

• 
  Forbion Capital Partners invested in Allecra Therapeutics. (4/18/13)
  Posted 4/20/13 at 3:01am via yahoo.com
• 
  Forbion Capital Partners invested in bluebird bio. (7/25/12)
  Posted 7/25/12 at 4:35am via yahoo.com
• 
  Forbion Capital Partners invested in Santaris Pharma. (6/21/12)
  Posted 6/21/12 at 7:09pm via dowjones.com
• 
  Forbion Capital Partners invested in Mitralign. (5/16/12)
  Posted 5/16/12 at 5:54pm via finsmes.com
• 
  Forbion Capital Partners invested in Argos Therapeutics. (4/24/12)
  Posted 4/24/12 at 5:49pm via argostherapeutics.com
• 
  Forbion Capital Partners invested in Promedior. (3/7/12)
  Posted 3/11/12 at 7:20pm via fiercebiotech.com
• 
  Forbion Capital Partners invested in arGEN-X. (12/1/11)
  Posted 12/1/11 at 5:11am via finsmes.com
• 
  Forbion Capital Partners invested in CircuLite. (11/30/11)
  Posted 11/30/11 at 5:16pm via finsmes.com
• 
  Forbion Capital Partners invested in Oxyrane UK. (11/17/11)
  Posted 11/17/11 at 8:25pm via finsmes.com
• 
  Forbion Capital Partners invested in Curetis. (10/26/11)
  Posted 10/26/11 at 7:38pm via curetis.com
• 
  Forbion Capital Partners invested in Hookipa Biotech. (10/18/11)
  Posted 10/18/11 at 8:08pm via fiercebiotech.com
• 
  Forbion Capital Partners invested in Amakem. (9/6/11)
  Posted 9/6/11 at 5:03am via prnewswire.com
• 
  Forbion Capital Partners invested in gIcare Pharma. (7/21/11)
  Posted 7/21/11 at 7:51pm via finsmes.com
• 
  Forbion Capital Partners invested in bluebird bio. (4/20/11)
  Posted 4/20/11 at 5:18am via live-pr.com
• 
  Forbion Capital Partners invested in CellNovo. (2/4/11)
  Posted 2/4/11 at 6:11pm via cellnovo.com
• 
  Forbion Capital Partners invested in PneumRx. (1/4/11)
  Posted 1/4/11 at 8:33pm via finsmes.com

Investments

Videos

Sources

1. Forbion Capital Amasses $313M For Two Health Care Venture Funds (fis.dowjones.com) [edit]
2. Forbion Capital Raises $50 Million to Invest in Health Companies (businessweek.com) [edit]
3. Edmond de Rothschild Investment Partners co-leads the €15 Million Series A financing of Allecra Therapeutics with its new fund BioDiscovery 4 (finance.yahoo.com) [edit]
4. bluebird bio Secures $60 Million in Oversubscribed Financing (in.finance.yahoo.com) [edit]
5. Denmark's Santaris Grabs $12M From Insiders for Clinical Trials (pevc.dowjones.com) [edit]
6. Mitralign Closes $35M in Series D Financing (finsmes.com) [edit]
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 (argostherapeutics.com) [edit]
8. Promedior lands $21.5M D round for fibrosis pipeline (fiercebiotech.com) [edit]
9. arGEN-X Closes €27.5M Series B Funding Round (finsmes.com) [edit]
10. CircuLite Raises $30M in Series D Funding (finsmes.com) [edit]
11. Oxyrane Raises $26.5M in Series D Funding (finsmes.com) [edit]
12. Series A financing round expended to 34.1 euro (curetis.com) [edit]
13. Hookipa Biotech Closes €7 million Series A Financing led by Sofinnova Partners (fiercebiotech.com) [edit]
14. Amakem Raises €18m in a Series a Round to Advance its Ophthalmology Drug Development Programs (prnewswire.com) [edit]
15. gIcare Pharma Closes CAD$7M Series A Financing (finsmes.com) [edit]
16. bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team (live-pr.com) [edit]
17. CELLNOVO SECURES £30 MILLION IN SERIES B FINANCING (cellnovo.com) [edit]
18. PneumRx Raises $33M (finsmes.com) [edit]
19. Cardoz AB Holds Second Close of SEK124M Series A Financing (finsmes.com) [edit]
20. Cytheris Closes €12 Million ($15 Million) Series D Financing (cytheris.com) [edit]
21. Exosome Diagnostics Completes $20 Million Series A Financing (exosomedx.com) [edit]
22. AltAssets (altassets.com) [edit]
23. Genetix raises $35M to advance gene therapies (fiercebiotech.com) [edit]
24. arGEN-X, BV: Series A $4.5M (onbiovc.com) [edit]
25. CircuLite Completes $32.5M Series C Financing (finsmes.com) [edit]
26. arGEN-X gins $13.6M in new funds for mAB work (fiercebiotech.com) [edit]
27. NiTi Surgical Solutions raises $18.5M (stlouis.bizjournals.com) [edit]
28. BioVex Raises $40 Million (fiercebiotech.com) [edit]
29. Pathway Medical lands generous $40M to treat arterial disease (venturebeat.com) [edit]